logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Rare Kidney Tumors Comprehensive Multidisciplinary Management And Emerging Therapies 1st Ed Gabriel G Malouf

  • SKU: BELL-7324368
Rare Kidney Tumors Comprehensive Multidisciplinary Management And Emerging Therapies 1st Ed Gabriel G Malouf
$ 31.00 $ 45.00 (-31%)

4.1

90 reviews

Rare Kidney Tumors Comprehensive Multidisciplinary Management And Emerging Therapies 1st Ed Gabriel G Malouf instant download after payment.

Publisher: Springer International Publishing
File Extension: PDF
File size: 2.83 MB
Author: Gabriel G. Malouf, Nizar M. Tannir
ISBN: 9783319969886, 9783319969893, 3319969889, 3319969897
Language: English
Year: 2019
Edition: 1st ed.

Product desciption

Rare Kidney Tumors Comprehensive Multidisciplinary Management And Emerging Therapies 1st Ed Gabriel G Malouf by Gabriel G. Malouf, Nizar M. Tannir 9783319969886, 9783319969893, 3319969889, 3319969897 instant download after payment.

This book provides clinicians with clear guidance on treatment decision-making in patients with rare kidney cancers. After a brief review on epidemiology, pathology, and biology, each chapter focuses on the multidisciplinary management of a particular tumor subtype using the full range of available cancer therapy modalities, including surgery, radiotherapy, chemotherapy, targeted therapies, and immunotherapy. Emerging therapies and future directions in the management of each cancer subtype are also discussed. The chapters are all written by multidisciplinary teams of international experts comprising at least a urologist, a medical oncologist, and a pathologist.

Rare kidney cancers represent 15% of renal cell carcinomas. In comparison with clear cell renal cell carcinomas, little is known about the biology of such cancers, and few trials have reported on the efficacy of targeted therapies in the metastatic setting. Optimal management thus poses significant challenges and often requires a multidisciplinary team. This book will be an ideal reference guide for all clinicians involved in the care of patients with these orphan tumors.

Related Products